{"content":"<li class=\"n-box-item date-title\" data-end=\"1387601999\" data-start=\"1387515600\" data-txt=\"Friday, December 20, 2019\">Friday, December 20, 2013</li><li class=\"n-box-item sa-box-item\" data-id=\"1478181\" data-ts=\"1387575158\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1478181-weekly-etf-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weekly ETF Gainers / Losers</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/pho' title='PowerShares Water Resources Portfolio ETF'>PHO</a> <font color='green'>+4.47%</font>. <a href='https://seekingalpha.com/symbol/xhb' title='SPDR Homebuilders ETF'>XHB</a> <font color='green'>+4.38%</font>. <a href='https://seekingalpha.com/symbol/iwc' title='iShares Micro-Cap ETF'>IWC</a> <font color='green'>+3.90%</font>. <a href='https://seekingalpha.com/symbol/iwm' title='iShares Russell 2000 ETF'>IWM</a> <font color='green'>+3.34%</font>. <a href='https://seekingalpha.com/symbol/bno' title='The United States Brent Oil ETF, LP'>BNO</a> <font color='green'>+3.18%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/gdxj' title='Market Vectors Junior Gold Miners ETF'>GDXJ</a> <font color='red'>-3.14%</font>. <a href='https://seekingalpha.com/symbol/iau' title='iShares Gold Trust ETF'>IAU</a> <font color='red'>-3.00%</font>. <a href='https://seekingalpha.com/symbol/gld' title='SPDR Gold Trust ETF'>GLD</a> <font color='red'>-2.88%</font>. <a href='https://seekingalpha.com/symbol/sgol' title='ETFS Physical Swiss Gold Trust ETF'>SGOL</a> <font color='red'>-2.86%</font>. <a href='https://seekingalpha.com/symbol/fxi' title='iShares China Large-Cap ETF'>FXI</a> <font color='red'>-2.81%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"1478181\" data-linked=\"Weekly ETF Gainers / Losers\" data-tweet=\"$PHO $XHB $IWC - Weekly ETF Gainers / Losers https://seekingalpha.com/news/1478181-weekly-etf-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1478181-weekly-etf-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1478091\" data-ts=\"1387572935\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XON\" target=\"_blank\">XON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1478091-intrexon-trades-higher-after-medistem-acquisition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intrexon trades higher after Medistem acquisition</a></h4><ul>\n<li>Shares of Intrexon (<a href=\"https://seekingalpha.com/symbol/XON\" title=\"Intrexon Corp\">XON</a> <font color=\"green\">+1.4%</font>) look to close modestly higher after the company's $26M deal for California-based Medistem (<a href=\"https://seekingalpha.com/symbol/MEDS\" title=\"Medistem, Inc.\">OTCQB:MEDS</a> <font color=\"green\">+47.7%</font>) which develops Endometrial Regenerative Cells.</li>\n<li>XON says the cells \"have the potential to provide treatments for conditions such as cancer, wound healing, and cardiovascular disease,\" when combined with integrated synthetic biology platforms.</li>\n<li>More specifically, XON plans to \"develop two powerful classes of clinical products\": Engineered stem cells for \"therapeutic delivery of secreted proteins\" and for \"producing exosomes.\"</li>\n<li>MEDS shareholders are getting $0.27 in cash and \"$1.08 worth of XON common stock.\" (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1478091\" data-linked=\"Intrexon trades higher after Medistem acquisition\" data-tweet=\"$XON $XON $MEDS-OLD - Intrexon trades higher after Medistem acquisition https://seekingalpha.com/news/1478091-intrexon-trades-higher-after-medistem-acquisition?source=tweet\" data-url=\"https://seekingalpha.com/news/1478091-intrexon-trades-higher-after-medistem-acquisition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1478041\" data-ts=\"1387570735\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WNR\" target=\"_blank\">WNR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1478041-shrinking-spreads-put-refiners-at-risk-cowen-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shrinking spreads put refiners at risk, Cowen says</a></h4><ul>     <li>Shrinking crude spreads - WTI has gained 7.2% while Brent has risen just 1.7% so far in December - likely <a href=\"http://blogs.barrons.com/stockstowatchtoday/2013/12/20/shrinking-spreads-put-refiners-at-risk-cowen-says\" target=\"_blank\">will hold back refiners</a> during the first six months of 2014, Cowen's Sam Margolin says.</li>     <li>Extremely favorable refining conditions from last month are  deteriorating amid higher utilization and continued reduction in crude  imports, limiting supply and causing U.S. prices to melt higher, the firm explains, adding that investors need  to \"manage near-term expectations\" while \"remain(ing) constructive on the refining story for 2014.\"</li>     <li>Margolin keeps Outperform ratings for Western Refining (<a href=\"https://seekingalpha.com/symbol/WNR\" title=\"Western Refining, Inc.\">WNR</a> <font color=\"green\">+4%</font>), Marathon Petroleum (<a href=\"https://seekingalpha.com/symbol/MPC\" title=\"Marathon Petroleum Corp.\">MPC</a> <font color=\"green\">+2.6%</font>), Tesoro (TSO <font color=\"green\">+0.4%</font>), Valero (<a href=\"https://seekingalpha.com/symbol/VLO\" title=\"Valero Energy Corporation\">VLO</a> <font color=\"green\">+1.4%</font>) and PBF Energy (<a href=\"https://seekingalpha.com/symbol/PBF\" title=\"PBF Energy\">PBF</a> <font color=\"green\">+1.7%</font>); HollyFrontier (<a href=\"https://seekingalpha.com/symbol/HFC\" title=\"HollyFrontier Corp.\">HFC</a> <font color=\"green\">+2.4%</font>), Delek (<a href=\"https://seekingalpha.com/symbol/DK\" title=\"Delek US Holdings, Inc.\">DK</a> <font color=\"green\">+2.3%</font>), Northern Tier (<a href=\"https://seekingalpha.com/symbol/NTI\" title=\"Northern Tier Energy\">NTI</a> <font color=\"green\">+0.6%</font>), Alon USA (<a href=\"https://seekingalpha.com/symbol/ALJ\" title=\"Alon USA Energy, Inc.\">ALJ</a> <font color=\"green\">+1.7%</font>) and Calumet Specialty Products (<a href=\"https://seekingalpha.com/symbol/CLMT\" title=\"Calumet Specialty Products Partners, L.P.\">CLMT</a> <font color=\"green\">+3.8%</font>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"1478041\" data-linked=\"Shrinking spreads put refiners at risk, Cowen says\" data-tweet=\"$WNR $WNR $MPC - Shrinking spreads put refiners at risk, Cowen says https://seekingalpha.com/news/1478041-shrinking-spreads-put-refiners-at-risk-cowen-says?source=tweet\" data-url=\"https://seekingalpha.com/news/1478041-shrinking-spreads-put-refiners-at-risk-cowen-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1477991\" data-ts=\"1387569229\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRVL\" target=\"_blank\">MRVL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1477991-cavium-slides-nomura-sees-major-challenges-ahead\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cavium slides; Nomura sees major challenges ahead</a></h4><ul>\n<li>Nomura is reiterating a Reduce on Cavium (CAVM <font color=\"red\">-2.9%</font>), and thinks the company faces major 2014 headwinds.</li>\n<li>Among them: The potential of the Cisco's <a href=\"https://seekingalpha.com/currents/post/1153252\" target=\"_blank\">acquisition</a> of Sourcefire to hurt sales - whereas Sourcefire has been a buyer of Cavium's network processors, Cisco relies heavily on home-grown ASICs - and the potential for Cavium's <a href=\"http://www.cavium.com/processor_Project_Thunder.html\" target=\"_blank\">Project Thunder</a> (developing ARM-based server CPUs) - to fail to meet expectations.</li>\n<li>SA contributor <a href=\"https://seekingalpha.com/article/1902621-cavium-networks-a-high-growth-networking-play-with-the-best-arm-server-play-built-in\" target=\"_blank\">Ashraf Eassa</a> recently made a bull case for Cavium in which he argued (among other things) Project Thunder's differentiated approach to the ARM server market - AMD, Marvell, and AppliedMicro are also targeting this space - could allow it to succeed. Instead of trying to compete head-on against Intel's dominant Xeon CPUs, Cavium is targeting a variety of niche applications where its integration of dedicated circuitry for specific tasks (i.e. offload engines) helps it stand out.</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/1469691\" target=\"_blank\">Shares rallied</a> earlier this week on hopes Avago's acquisition of network processor vendor LSI would lead to M&amp;A interest in Cavium.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1477991\" data-linked=\"Cavium slides; Nomura sees major challenges ahead\" data-tweet=\"$MRVL - Cavium slides; Nomura sees major challenges ahead https://seekingalpha.com/news/1477991-cavium-slides-nomura-sees-major-challenges-ahead?source=tweet\" data-url=\"https://seekingalpha.com/news/1477991-cavium-slides-nomura-sees-major-challenges-ahead\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1477931\" data-ts=\"1387567768\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IRDM\" target=\"_blank\">IRDM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1477931-iridium-rallies-air-traffic-venture-receives-funding-promises-payments\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Iridium rallies; air traffic venture receives funding, promises payments</a></h4><ul>\n<li>Iridium's (<a href=\"https://seekingalpha.com/symbol/IRDM\" title=\"Iridium Communications Inc\">IRDM</a> <font color=\"green\">+6.4%</font>) <a href=\"http://www.aireon.com/Solutions/TheGlobalAdvantage\" target=\"_blank\">Aireon</a> venture, provider of (according to Iridium) the world's first air traffic surveillance system to rely on satellites, is receiving $120M in investments from three air navigation service providers: Denmark's Navair, Italy's ENAV, and the Irish Aviation Authority. (PR)</li>\n<li>The investments have strings attached: They'll give the investors preferred interests, will be provided in tranches from 2014-2017, and require Aireon to redeem part of Iridium's stake in the company, likely in 2018. Following the redemption, Iridium will have only a 24.5% stake in Aireon. NAV Canada will own 51%.</li>\n<li>But Iridium may be less interested in its equity stake than its ability to profit from sales to Aireon. In tandem with the investments, Aireon has promised to pay Iridium in hosting fees for placing receiver payloads on <a href=\"http://www.iridium.com/about/iridiumnext.aspx\" target=\"_blank\">Iridium NEXT satellites</a>, and nearly $300M in data service fees through 2030.</li>\n<li>Aireon declares its solution, which allows air traffic surveillance to be extended to oceans and remote areas, will deliver \"increased efficiencies and fuel savings\" for airlines.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1477931\" data-linked=\"Iridium rallies; air traffic venture receives funding, promises payments\" data-tweet=\"$IRDM - Iridium rallies; air traffic venture receives funding, promises payments https://seekingalpha.com/news/1477931-iridium-rallies-air-traffic-venture-receives-funding-promises-payments?source=tweet\" data-url=\"https://seekingalpha.com/news/1477931-iridium-rallies-air-traffic-venture-receives-funding-promises-payments\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1477911\" data-ts=\"1387567419\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VALE\" target=\"_blank\">VALE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1477911-brazils-vale-cemig-create-venture-for-energy-assets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brazil&#39;s Vale, Cemig create venture for energy assets</a></h4><ul>     <li>Vale (<a href=\"https://seekingalpha.com/symbol/VALE\" title=\"Vale S.A.\">VALE</a> <font color=\"red\">-2.4%</font>) is forming a joint venture with power company Cemig (NYSE:<a href=\"https://seekingalpha.com/symbol/CIG\" title=\"Companhia Energtica de Minas Gerais - CEMIG\">CIG</a>) to <a href=\"http://online.wsj.com/news/articles/SB10001424052702304866904579270333761778364\" target=\"_blank\">manage some energy assets</a> and to sell part of its stake in the controversial Belo Monte hydroelectric dam in the Amazon forest, part of its efforts to cut costs and focus on its main iron ore mining business.</li>     <li>The JV will comprise Vale and Cemig stakes in six hydroelectric power plants, with a total installed capacity of 1,158 MW.</li>     <li>Vale doesn't disclose the potential value of the assets to be included in the new company, but Cemig says its 45% stake is valued at 2.03B Brazilian reais ($874M).</li> </ul><div class=\"tiny-share-widget\" data-id=\"1477911\" data-linked=\"Brazil&#39;s Vale, Cemig create venture for energy assets\" data-tweet=\"$VALE $VALE $CIG - Brazil&#39;s Vale, Cemig create venture for energy assets https://seekingalpha.com/news/1477911-brazils-vale-cemig-create-venture-for-energy-assets?source=tweet\" data-url=\"https://seekingalpha.com/news/1477911-brazils-vale-cemig-create-venture-for-energy-assets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1477841\" data-ts=\"1387566184\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1477841-blackberry-shooting-higher-chen-expects-fy16-profits\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BlackBerry shooting higher; Chen expects FY16 profits</a></h4><ul>\n<li>With a lot of bad news priced in, BlackBerry (BBRY <font color=\"green\">+13.6%</font>) has shot higher following its FQ3 report, as investors applaud a Foxconn deal that (for now) will limit BlackBerry's in-house phone design work to a limited number of high-end enterprise devices. Talking to CNBC (<a href=\"http://www.cnbc.com/id/101289411\" target=\"_blank\">video</a>), John Chen asserts the deal will help BlackBerry become profitable by FY16 (ends Feb. '16).</li>\n<li>Chen: \"The number one thing I noticed (as CEO) was that our handset volume was dropping and with that, our [fixed] cost was too high ... [Foxconn] has the ability to bring the cost down ... The focus of the overall company is shifting toward enterprise, government customers and software services.\"</li>\n<li>With BlackBerry <a href=\"http://finance.yahoo.com/q/ae?s=BBRY+Analyst+Estimates\" target=\"_blank\">expected</a> to lose $1.37/share in FY14 and $1.10/share in FY15,  a return to profitability in FY16 would represent a major turnaround.</li>\n<li>Also: On the CC (<a href=\"https://seekingalpha.com/article/1909681-blackberry-ceo-discusses-f3q14-results-earnings-call-transcript?part=single\" target=\"_blank\">transcript</a>), Chen stated BlackBerry is aiming to become \"cash flow neutral from operations\" in FY15, and expects \"reasonably good revenue\" from BBM around the FY16 timeframe.</li>\n<li>Short-covering is likely contributing to today's gains: 33% of the float was shorted as of Nov. 29.</li>\n<li><a href=\"https://seekingalpha.com/currents/search?query=bbry\" target=\"_blank\">More on BlackBerry</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1477841\" data-linked=\"BlackBerry shooting higher; Chen expects FY16 profits\" data-tweet=\"$BB - BlackBerry shooting higher; Chen expects FY16 profits https://seekingalpha.com/news/1477841-blackberry-shooting-higher-chen-expects-fy16-profits?source=tweet\" data-url=\"https://seekingalpha.com/news/1477841-blackberry-shooting-higher-chen-expects-fy16-profits\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1477811\" data-ts=\"1387564479\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INFN\" target=\"_blank\">INFN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1477811-infinera-higher-following-fbr-coverage-launch-peer-group-also-rallying\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Infinera higher following FBR coverage launch; peer group also rallying</a></h4><ul>     <li>FBR's <a href=\"http://www.streetinsider.com/New+Coverage/FBR+Capital+Starts+Infinera+Corp.+%28INFN%29+at+Outperform/8997570.html\" target=\"_blank\">Scott Thompson</a> has started coverage on Infinera (<a href=\"https://seekingalpha.com/symbol/INFN\" title=\"Infinera Corporation\">INFN</a> <font color=\"green\">+1.6%</font>) with an Outperform and $12.50 PT. He expects the optical networking space to \"experience stronger performance in 2014 versus 2013\" thanks to several catalysts he expects will \"one of the strongest optical cycles the industry has seen in more than two decades.\"</li>     <li>Thompson also reiterates an argument he made in a <a href=\"https://seekingalpha.com/currents/post/1446021\" target=\"_blank\">Dec. 4 note</a> on Ciena (<a href=\"https://seekingalpha.com/symbol/CIEN\" title=\"Ciena Corporation\">CIEN</a> <font color=\"green\">+2.3%</font>): That telecom networks are migrating towards architectures that offer greater optical layer intelligence/flexibility, and in doing so require less money to be spent on switches/routers.</li>\n<li>Thompson thinks this architecture shift is partly responsible for <a href=\"https://seekingalpha.com/currents/post/1411432\" target=\"_blank\">the recent weakness</a> seen in Cisco's (<a href=\"https://seekingalpha.com/symbol/CSCO\" title=\"Cisco Systems, Inc.\">CSCO</a> <font color=\"green\">+0.6%</font>) service provider sales.</li>     <li>As for Infinera, a major player in the 100G optical transmission space, Thompson declares the company to have the strongest exposure to the optical segments where \"the shift will be the most pronounced.\"</li>     <li>In addition to Infinera and Ciena, a couple other optical networking hardware vendors are doing well on a good day for tech, as are some component suppliers. CYNI <font color=\"green\">+4.3%</font>. <a href=\"https://seekingalpha.com/symbol/AFOP\" title=\"Alliance Fiber Optic Products, Inc.\">AFOP</a> <font color=\"green\">+5.9%</font>. <a href=\"https://seekingalpha.com/symbol/OPLK\" title=\"Oplink Communications, Inc.\">OPLK</a> <font color=\"green\">+2.8%</font>. <a href=\"https://seekingalpha.com/symbol/OCLR\" title=\"Oclaro, Inc.\">OCLR</a> <font color=\"green\">+2.4%</font>. <a href=\"https://seekingalpha.com/symbol/ADTN\" title=\"ADTRAN, Inc.\">ADTN</a> <font color=\"green\">+1.9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1477811\" data-linked=\"Infinera higher following FBR coverage launch; peer group also rallying\" data-tweet=\"$INFN $INFN $CIEN - Infinera higher following FBR coverage launch; peer group also rallying https://seekingalpha.com/news/1477811-infinera-higher-following-fbr-coverage-launch-peer-group-also-rallying?source=tweet\" data-url=\"https://seekingalpha.com/news/1477811-infinera-higher-following-fbr-coverage-launch-peer-group-also-rallying\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1477761\" data-ts=\"1387563249\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NAVB\" target=\"_blank\">NAVB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1477761-navidea-biopharmaceuticals-talks-maa-for-lymphoseek-shares-slide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Navidea Biopharmaceuticals talks MAA for Lymphoseek, shares slide</a></h4><ul>\n<li>Navidea Biopharmaceuticals (<a href=\"https://seekingalpha.com/symbol/NAVB\" title=\"Navidea Biopharmaceuticals\">NAVB</a> <font color=\"red\">-6.7%</font>) slides after saying the EMA \"has provided       updated Day 180 feedback and has elected to continue the assessment of the\" <a href=\"https://seekingalpha.com/currents/search?query=Lymphoseek\" target=\"_blank\">Lymphoseek</a> MAA.</li>\n<li>The company notes that there was \"less time for evaluation ... of new data\" as Phase 3 Head and Neck Cancer results were submitted \"later in the MAA review process at Day 120.\"</li>\n<li>Here's CEO Mark Pykett: \"With the Lymphoseek MAA remaining in the EMA's assessment process, we       will continue to work with the EMA to support a positive opinion as       early as possible in 2014.\"</li>\n<li>NAVB says it still sees its plans for European market development supporting \"material revenue generation from Europe beginning in 2015.\" (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1477761\" data-linked=\"Navidea Biopharmaceuticals talks MAA for Lymphoseek, shares slide\" data-tweet=\"$NAVB - Navidea Biopharmaceuticals talks MAA for Lymphoseek, shares slide https://seekingalpha.com/news/1477761-navidea-biopharmaceuticals-talks-maa-for-lymphoseek-shares-slide?source=tweet\" data-url=\"https://seekingalpha.com/news/1477761-navidea-biopharmaceuticals-talks-maa-for-lymphoseek-shares-slide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1477671\" data-ts=\"1387561567\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1477671-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday gainers / Losers</a></h4><ul>     <li>\n<b>Top 10 Gainers:</b> <a href=\"https://seekingalpha.com/symbol/TSEM\" title=\"Tower Semiconductor Ltd.\">TSEM</a> <font color=\"green\">+59%</font>. <a href=\"https://seekingalpha.com/symbol/ORMP\" title=\"Oramed Pharmaceuticals Inc.\">ORMP</a> <font color=\"green\">+53%</font>. <a href=\"https://seekingalpha.com/symbol/MKTG\" title=\"Responsys\">MKTG</a> <font color=\"green\">+39%</font>. <a href=\"https://seekingalpha.com/symbol/AMRN\" title=\"Amarin Corporation PLC\">AMRN</a> <font color=\"green\">+25%</font>. <a href=\"https://seekingalpha.com/symbol/ARIA\" title=\"ARIAD Pharmaceuticals, Inc.\">ARIA</a> <font color=\"green\">+22%</font>. <a href=\"https://seekingalpha.com/symbol/RHT\" title=\"Red Hat, Inc.\">RHT</a> <font color=\"green\">+18%</font>. <a href=\"https://seekingalpha.com/symbol/AVNR\" title=\"Avanir Pharmaceuticals, Inc\">AVNR</a> <font color=\"green\">+16%</font>. <a href=\"https://seekingalpha.com/symbol/AMBA\" title=\"Ambarella\">AMBA</a> <font color=\"green\">+13%</font>. <a href=\"https://seekingalpha.com/symbol/PRTS\" title=\"U.S. Auto Parts Network, Inc.\">PRTS</a> <font color=\"green\">+13%</font>. <a href=\"https://seekingalpha.com/symbol/GTXI\" title=\"GTx, Inc.\">GTXI</a> <font color=\"green\">+13%</font>.</li>\n<li>\n<b>Top 10 Losers:</b> <a href=\"https://seekingalpha.com/symbol/MD\" title=\"Mednax, Inc.\">MD</a> <font color=\"red\">-50%</font>. <a href=\"https://seekingalpha.com/symbol/LTON\" title=\"Linktone Ltd.\">LTON</a> <font color=\"red\">-29%</font>. WPCS <font color=\"red\">-14%</font>. <a href=\"https://seekingalpha.com/symbol/KUTV\" title=\"Ku6 Media Co., Ltd.\">KUTV</a> <font color=\"red\">-14%</font>. <a href=\"https://seekingalpha.com/symbol/TIBX\" title=\"TIBCO Software, Inc.\">TIBX</a> <font color=\"red\">-14%</font>. IFON <font color=\"red\">-12%</font>. <a href=\"https://seekingalpha.com/symbol/CLWT\" title=\"Euro Tech Holdings Company Limited\">CLWT</a> <font color=\"red\">-10%</font>. EONC <font color=\"red\">-10%</font>. <a href=\"https://seekingalpha.com/symbol/PURE\" title=\"PURE Bioscience\">OTC:PURE</a> <font color=\"red\">-10%</font>. <a href=\"https://seekingalpha.com/symbol/MARPS\" title=\"Marine Petroleum Trust\">MARPS</a> <font color=\"red\">-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1477671\" data-linked=\"Midday gainers / Losers\" data-tweet=\"$TSEM $ORMP $MKTG - Midday gainers / Losers https://seekingalpha.com/news/1477671-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1477671-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1477601\" data-ts=\"1387561089\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NMBL\" target=\"_blank\">NMBL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1477601-new-post-ipo-highs-for-nimble-storage-following-rbc-launch\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New post-IPO highs for Nimble Storage following RBC launch</a></h4><ul>\n<li>A week after Nimble Storage (<a href=\"https://seekingalpha.com/symbol/NMBL\" title=\"Nimble Storage, Inc.\">NMBL</a> <font color=\"green\">+7.2%</font>) <a href=\"https://seekingalpha.com/currents/post/1464071\" target=\"_blank\">blasted off</a> post-IPO, RBC (not an underwriter) has <a href=\"http://blogs.barrons.com/techtraderdaily/2013/12/19/nimble-rbc-starts-at-buy-40-target-great-take-out-potential/?mod=tech\" target=\"_blank\">started coverage</a> on the maker of hybrid flash/hard drive storage systems with an Outperform and $40 PT.</li>\n<li>Analyst Amit Daryanani praises the \"extremely attractive\" price/performance ratio (i.e. $/IOPS) delivered by Nimble's proprietary CASL architecture (<a href=\"https://seekingalpha.com/currents/post/1338272\" target=\"_blank\">previous</a>), which he believes allows the company's hardware to \"provide the same capacity and <a href=\"http://en.wikipedia.org/wiki/IOPS\" target=\"_blank\">IOPS</a> as its peers using only 35-50% of the hardware.\"</li>\n<li>This advantage stems from the ability of Nimble's software to convert random writes produced by apps (better handled by flash memory) into sequential writes (better handled by hard drives, still much cheaper than flash).</li>\n<li>Daryanani also notes Nimble's ability to natively support inline compression (compression that takes place as data is being stored) using a proprietary algorithm allows it to \"store up to 75% more data per gigabyte with minimal impact on performance or additional latency.\" Though rivals <a href=\"http://www.computerworld.com/s/article/9227727/IBM_adds_inline_compression_other_upgrades_to_storage_systems\" target=\"_blank\">also support </a>inline compression, Nimble's offering is unique in its ability to support variable storage block sizes.</li>\n<li>Though the company now has a $2.7B market cap and trades at lofty multiples, Daryanani thinks Nimble could be an M&amp;A target, given <a href=\"https://seekingalpha.com/currents/post/1269912\" target=\"_blank\">recent activity</a>. Shares are now <font color=\"green\">up 83%</font> from an IPO price of $21.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1477601\" data-linked=\"New post-IPO highs for Nimble Storage following RBC launch\" data-tweet=\"$NMBL - New post-IPO highs for Nimble Storage following RBC launch https://seekingalpha.com/news/1477601-new-post-ipo-highs-for-nimble-storage-following-rbc-launch?source=tweet\" data-url=\"https://seekingalpha.com/news/1477601-new-post-ipo-highs-for-nimble-storage-following-rbc-launch\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1477431\" data-ts=\"1387559578\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WMC\" target=\"_blank\">WMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1477431-western-asset-above-book-value-short-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Western Asset above book value - short target?</a></h4><ul>\n<li>\"Do the math,\" says SA contributor REIT Analyst,<a href=\"https://seekingalpha.com/author/reit-analyst/stocktalk/36077161\" target=\"_blank\"> eyeing a short opportunity</a> in Western Asset Management (<a href=\"https://seekingalpha.com/symbol/WMC\" title=\"Western Asset Mortgage Capital Corporation\">WMC</a> <font color=\"green\">+5.4%</font>) following its surprising <a href=\"https://seekingalpha.com/currents/post/1475821\" target=\"_blank\">$2.35 dividend announcement </a>last night.</li>\n<li>The rise in the stock today puts it above November 30 estimated book value per share of $16.76 - this at a time when the rest of the mREIT sector (<a href=\"https://seekingalpha.com/symbol/REM\" title=\"iShares Mortgage Real Estate Capped ETF\">REM</a><font color=\"green\">+1.2%</font>) is trading at a significant discount to book, including American Capital Agency (<a href=\"https://seekingalpha.com/symbol/AGNC\" title=\"AGNC Investment Corp.\">AGNC</a> <font color=\"green\">+1.3%</font>) at more than a 20% discount, and Anworth (<a href=\"https://seekingalpha.com/symbol/ANH\" title=\"Anworth Mortgage Asset Corporation\">ANH</a><font color=\"green\">+1%</font>) at nearly 30% - just to name two. And don't forget the dilutive share issuance necessary to pay out the stock portion of the dividend.</li>\n<li>Among others who announced dividends last night, Annaly (<a href=\"https://seekingalpha.com/symbol/NLY\" title=\"Annaly Capital Management, Inc.\">NLY</a> <font color=\"green\">+2.1%</font>) gains after surprising no one by cutting a nickel to $0.30, and Chimera (<a href=\"https://seekingalpha.com/symbol/CIM\" title=\"Chimera Investment Corporation\">CIM</a><font color=\"green\">+2.2%</font>) rises after announcing a special $0.20 dividend.</li>\n<li>Lumped in with the mREITs, but with a slightly different business model is Arlington Asset Management (<a href=\"https://seekingalpha.com/symbol/AI\" title=\"Arlington Asset Investment Corporation\">AI</a> <font color=\"green\">+3.3%</font>) which continues a big run this year after <a href=\"https://seekingalpha.com/currents/post/1475711\" target=\"_blank\">holding its payout steady</a>. SA contributor Darren McCammon reminds Arlington is a C corp, so - for taxable accounts - its yield is taxed at lower qualified rates, making its 13.4% annualized payout comparable to an mREIT paying 16%. Check <a href=\"https://seekingalpha.com/instablog/379412-darren-mccammon/2512091-why-has-arlington-asset-investments-ai-done-so-much-better-than-other-mreits\" target=\"_blank\">McCammon's post </a>for the rest of the advantages. The stock is <font color=\"green\">up 28% </font>YTD vs. big declines for the mREIT sector.</li>\n<li>Related ETFs: <a href=\"https://seekingalpha.com/symbol/MORT\" title=\"VanEck Vectors Mortgage REIT Income ETF\">MORT</a>, <a href=\"https://seekingalpha.com/symbol/MORL\" title=\"UBS ETRACS Monthly Pay 2x Leveraged Mortgage REIT ETN\">MORL</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1477431\" data-linked=\"Western Asset above book value - short target?\" data-tweet=\"$WMC $WMC $REM - Western Asset above book value - short target? https://seekingalpha.com/news/1477431-western-asset-above-book-value-short-target?source=tweet\" data-url=\"https://seekingalpha.com/news/1477431-western-asset-above-book-value-short-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1477421\" data-ts=\"1387559333\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/S\" target=\"_blank\">S</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1477421-sprint-rallies-banks-reportedly-prepping-financing-for-t-mobile-bid\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sprint rallies; banks reportedly prepping financing for T-Mobile bid</a></h4><ul>\n<li>\n<a href=\"http://online.wsj.com/news/articles/SB10001424052702304773104579268954112243572\" target=\"_blank\">The <em>WSJ</em> reports</a> at least six banks are working on financing proposals for a Sprint (<a href=\"https://seekingalpha.com/symbol/S\" title=\"Sprint Corporation\">S</a> <font color=\"green\">+3%</font>) bid for T-Mobile USA (<a href=\"https://seekingalpha.com/symbol/TMUS\" title=\"T-Mobile US, Inc.\">TMUS</a> <font color=\"green\">+0.7%</font>). Sprint, whose shares jumped a week ago when the paper <a href=\"https://seekingalpha.com/currents/post/1465011\" target=\"_blank\">first reported</a> the carrier is thinking of making an offer for its smaller rival, is now <font color=\"green\">up 16%</font> since the initial report arrived.</li>\n<li>Financing or not, close regulatory scrutiny of a proposed merger between the third and fourth-largest U.S. mobile carriers is a given. <a href=\"https://seekingalpha.com/currents/post/1474401\" target=\"_blank\">JPMorgan</a> noted yesterday a Dish (<a href=\"https://seekingalpha.com/symbol/DISH\" title=\"DISH Network Corporation\">DISH</a> <font color=\"green\">+1.6%</font>) bid for T-Mobile (<a href=\"https://seekingalpha.com/symbol/TMUS\" title=\"T-Mobile US, Inc.\">TMUS</a> <font color=\"green\">+0.7%</font>), also <a href=\"https://seekingalpha.com/currents/post/1472521\" target=\"_blank\">reportedly being weighed</a>, would have much less trouble being cleared by regulators.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1477421\" data-linked=\"Sprint rallies; banks reportedly prepping financing for T-Mobile bid\" data-tweet=\"$S $S $TMUS - Sprint rallies; banks reportedly prepping financing for T-Mobile bid https://seekingalpha.com/news/1477421-sprint-rallies-banks-reportedly-prepping-financing-for-t-mobile-bid?source=tweet\" data-url=\"https://seekingalpha.com/news/1477421-sprint-rallies-banks-reportedly-prepping-financing-for-t-mobile-bid\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1477361\" data-ts=\"1387557863\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STX\" target=\"_blank\">STX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1477361-seagate-rallies-western-digital-ticks-higher-following-pt-hikes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seagate rallies, Western Digital ticks higher following PT hikes</a></h4><ul>\n<li>Brean's <a href=\"http://www.streetinsider.com/Analyst+Comments/Western+Digital+%28WDC%29+Seagate+%28STX%29+PTs+Raised+at+Brean+Capital/8999646.html\" target=\"_blank\">Ananda Baruah</a> has raised his Seagate (<a href=\"https://seekingalpha.com/symbol/STX\" title=\"Seagate Technology\">STX</a> <font color=\"green\">+4.1%</font>) PT to $70 from $55, and his Western Digital (<a href=\"https://seekingalpha.com/symbol/WDC\" title=\"Western Digital Corporation\">WDC</a> <font color=\"green\">+0.9%</font>) PT to $125 from $85, while reiterating Buys for both names. The PT hikes come shortly after the hard drive giants respectively  received upgrades to Overweight and Buy from <a href=\"https://seekingalpha.com/currents/post/1468701\" target=\"_blank\">JPMorgan</a> and <a href=\"https://seekingalpha.com/currents/post/1463801\" target=\"_blank\">Citi</a>.</li>\n<li>With industry consolidation keeping pricing healthy, Baruah thinks Seagate/Western can deliver 100-200 bps of gross margin improvement over the next few years, and perhaps 400-500 of improvement within 5-7 years.</li>\n<li>That, in turn, leads him to forecast Seagate and Western willrespectively deliver $7+ and $8.64 in calendar 2015 EPS. He add cost savings obtained from integrating Hitachi's hard drive unit could boost Western's EPS by another ~$1.70. For reference, Seagate's current FY15 (ends June '15) EPS consensus is at $5.96, and Western's is at $8.59.</li>\n<li>Seagate has made new 52-week highs, and Western is close to its 52-week high of $84.70.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1477361\" data-linked=\"Seagate rallies, Western Digital ticks higher following PT hikes\" data-tweet=\"$STX $STX $WDC - Seagate rallies, Western Digital ticks higher following PT hikes https://seekingalpha.com/news/1477361-seagate-rallies-western-digital-ticks-higher-following-pt-hikes?source=tweet\" data-url=\"https://seekingalpha.com/news/1477361-seagate-rallies-western-digital-ticks-higher-following-pt-hikes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1477251\" data-ts=\"1387555331\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HIMX\" target=\"_blank\">HIMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1477251-himax-rallies-in-response-to-topeka-coverage-launch\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Himax rallies in response to Topeka coverage launch</a></h4><ul>\n<li>Topeka's <a href=\"http://www.streetinsider.com/Analyst+Comments/Topeka+Capital+Sees+Growth+Opp+in+Himax+Technologies+%28HIMX%29%2C+Starts+at+Buy/8997175.html\" target=\"_blank\">Suji De Silva</a> has started coverage on Himax (<a href=\"https://seekingalpha.com/symbol/HIMX\" title=\"Himax Technologies, Inc.\">HIMX</a> <font color=\"green\">+2.4%</font>) with a Buy and $16 PT.</li>\n<li>De Silva praises the company's \"increasingly diversified portfolio of display-related products,\" and is also upbeat about future margin expansion and the \"resumption of healthy sequential growth\" for Himax's large-panel LCD driver business (lately <a href=\"https://seekingalpha.com/currents/post/1395112\" target=\"_blank\">under pressure</a> due to TV/PC weakness).</li>\n<li>The launch comes a day after <a href=\"https://seekingalpha.com/currents/post/1474261\" target=\"_blank\">Craig-Hallum</a> forecast a strong Q4, and four days after Northland raised its PT to $15 from $12.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1477251\" data-linked=\"Himax rallies in response to Topeka coverage launch\" data-tweet=\"$HIMX - Himax rallies in response to Topeka coverage launch https://seekingalpha.com/news/1477251-himax-rallies-in-response-to-topeka-coverage-launch?source=tweet\" data-url=\"https://seekingalpha.com/news/1477251-himax-rallies-in-response-to-topeka-coverage-launch\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1477201\" data-ts=\"1387554780\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCCO\" target=\"_blank\">SCCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1477201-peru-expects-approval-for-delayed-southern-copper-project\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Peru expects approval for delayed Southern Copper project</a></h4><ul>     <li>Peru <a href=\"http://online.wsj.com/news/articles/SB10001424052702303773704579270152236301942\" target=\"_blank\">expects to approve a key environmental permit</a> for the development of Southern Copper's (<a href=\"https://seekingalpha.com/symbol/SCCO\" title=\"Southern Copper Corporation\">SCCO</a> <font color=\"green\">+1.9%</font>) delayed Tia Maria copper mine project within the next 90 days, a top government official says after meeting with local residents.</li>     <li>Tia Maria was suspended in 2011 after violent protests from opponents worried that it would deplete the water supply for local agriculture, but SCCO has since reworked its environmental study and says the new mine plan addresses local concerns.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"1477201\" data-linked=\"Peru expects approval for delayed Southern Copper project\" data-tweet=\"$SCCO - Peru expects approval for delayed Southern Copper project https://seekingalpha.com/news/1477201-peru-expects-approval-for-delayed-southern-copper-project?source=tweet\" data-url=\"https://seekingalpha.com/news/1477201-peru-expects-approval-for-delayed-southern-copper-project\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1477171\" data-ts=\"1387554294\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MWW\" target=\"_blank\">MWW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1477171-monster-makes-new-52-week-highs-following-avondale-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Monster makes new 52-week highs following Avondale upgrade</a></h4><ul>\n<li>Avondale Partners has upgraded Monster (<a href=\"https://seekingalpha.com/symbol/MWW\" title=\"Monster Worldwide, Inc.\">MWW</a> <font color=\"green\">+6.8%</font>) to Market Perform, and raised its PT to $7 from $4. The upgrade comes a month after FBR <a href=\"https://seekingalpha.com/currents/post/1425731\" target=\"_blank\">started coverage</a> on the jobs site with an Outperform, while calling it a play on job growth, strategic initiatives (such as its <a href=\"https://seekingalpha.com/currents/post/1396332\" target=\"_blank\">Korean/European JVs</a>).</li>\n<li>Monster, pressured for a long time by concerns about declining sales and share loss to LinkedIn, is making new 52-week highs. Shares are <font color=\"green\">up 19%</font> YTD.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1477171\" data-linked=\"Monster makes new 52-week highs following Avondale upgrade\" data-tweet=\"$MWW - Monster makes new 52-week highs following Avondale upgrade https://seekingalpha.com/news/1477171-monster-makes-new-52-week-highs-following-avondale-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/1477171-monster-makes-new-52-week-highs-following-avondale-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1477161\" data-ts=\"1387554204\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MHRCQ\" target=\"_blank\">MHRCQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1477161-magnum-hunter-plus-3_8-percent-after-operational-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Magnum Hunter +3.8% after operational update</a></h4><ul>     <li>Magnum Hunter (MHR <font color=\"green\">+3.8%</font>) is on the rise after providing an operational update on new wells drilled in the Marcellus and Utica shale plays.</li>     <li>MHR has drilled and completed three wells at the Ormet Pad in Ohio and four wells at the Collins Pad in West Virginia; at the latter site, one well tested at 10K cf/day and another at 9,850 cf/day.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1477161\" data-linked=\"Magnum Hunter +3.8% after operational update\" data-tweet=\"$MHRCQ - Magnum Hunter +3.8% after operational update https://seekingalpha.com/news/1477161-magnum-hunter-plus-3_8-percent-after-operational-update?source=tweet\" data-url=\"https://seekingalpha.com/news/1477161-magnum-hunter-plus-3_8-percent-after-operational-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1477111\" data-ts=\"1387553398\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMBA\" target=\"_blank\">AMBA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1477111-ambarella-jumps-to-new-highs-on-news-of-google-partnership\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ambarella jumps to new highs on news of Google partnership</a></h4><ul>\n<li>Ambarella (<a href=\"https://seekingalpha.com/symbol/AMBA\" title=\"Ambarella\">AMBA</a> <font color=\"green\">+11.2%</font>) announces it's working with Google (<a href=\"https://seekingalpha.com/symbol/GOOG\" title=\"Alphabet, Inc. Cl C\">GOOG</a> <font color=\"green\">+0.7%</font>) on \"a new class of wearable cameras\" that supports the Web giant's <a href=\"https://helpouts.google.com/home\" target=\"_blank\">Helpouts</a> live video-based instructional/teaching service. (PR)</li>\n<li>Leveraging one of its video-processing SoCs, Ambarella has created a reference design enabling \"small form factor wearable cameras that allow users complete mobility during a Helpouts session.\" The cameras support the simultaneous recording and Wi-Fi-based streaming of full HD video, as well as image stabilization.</li>\n<li>Ambarella, which delivered an <a href=\"https://seekingalpha.com/currents/post/1448961\" target=\"_blank\">FQ3 beat</a> earlier this month, is making new highs, and is now <strong><font color=\"green\">up 146%</font></strong> YTD.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1477111\" data-linked=\"Ambarella jumps to new highs on news of Google partnership\" data-tweet=\"$AMBA $AMBA $GOOG - Ambarella jumps to new highs on news of Google partnership https://seekingalpha.com/news/1477111-ambarella-jumps-to-new-highs-on-news-of-google-partnership?source=tweet\" data-url=\"https://seekingalpha.com/news/1477111-ambarella-jumps-to-new-highs-on-news-of-google-partnership\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1477101\" data-ts=\"1387553302\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNY\" target=\"_blank\">JNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1477101-deal-done-sycamore-partners-nabs-the-jones-group\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deal done: Sycamore Partners nabs The Jones Group</a></h4><ul> <li>Jones Group (<a href=\"https://seekingalpha.com/symbol/JNY\" title=\"The Jones Group Inc.\">JNY</a> <font color=\"green\">+4.8%</font>) has officially been acquired by P-E firm Sycamore Partners for $15.00 per share in a $2.2B deal.</li> <li>The transaction is expected to close in Q2 of 2014.</li> <li>Shares of The Jones Group have been active ever since reports on the buyout first filtered out earlier in the month.</li> <li><a href=\"https://seekingalpha.com/currents/search?query=jny%20sycamore\" target=\"_blank\">Sycamore-JNY timeline</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"1477101\" data-linked=\"Deal done: Sycamore Partners nabs The Jones Group\" data-tweet=\"$JNY - Deal done: Sycamore Partners nabs The Jones Group https://seekingalpha.com/news/1477101-deal-done-sycamore-partners-nabs-the-jones-group?source=tweet\" data-url=\"https://seekingalpha.com/news/1477101-deal-done-sycamore-partners-nabs-the-jones-group\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1477071\" data-ts=\"1387552821\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARIA\" target=\"_blank\">ARIA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1477071-ariads-iclusig-set-for-market-return-after-fda-approves-revised-uspi-and-rems\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ariad&#39;s Iclusig set for market return after FDA approves revised USPI and REMS</a></h4><ul>\n<li>Ariad Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/ARIA\" title=\"ARIAD Pharmaceuticals, Inc.\">ARIA</a> <font color=\"green\">+21.9%</font>) says the FDA has approved a revised USPI and a REMS for <a href=\"https://seekingalpha.com/currents/search?query=iclusig\" target=\"_blank\">Iclusig</a>.</li>\n<li><em>The move \"allows immediate resumption of       its marketing and commercial distribution.\" </em></li>\n<li>The drug, which was <a href=\"https://seekingalpha.com/currents/post/1373692\" target=\"_blank\">suspended</a> in October, is now indicated for \"T315I-positive chronic myeloid leukemia or T315I-positive Philadelphia chromosome         positive acute lymphoblastic leukemia and chronic phase, accelerated phase, or blast phase chronic myeloid         leukemia or Ph+ acute lymphoblastic leukemia for whom no other         tyrosine-kinase inhibitor therapy is indicated.\"</li>\n<li>The boxed warning is revised and now features an alert regarding \"the risk of vascular occlusive events.\" There's also \"a new warning for heart failure.\" (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1477071\" data-linked=\"Ariad&#39;s Iclusig set for market return after FDA approves revised USPI and REMS\" data-tweet=\"$ARIA - Ariad&#39;s Iclusig set for market return after FDA approves revised USPI and REMS https://seekingalpha.com/news/1477071-ariads-iclusig-set-for-market-return-after-fda-approves-revised-uspi-and-rems?source=tweet\" data-url=\"https://seekingalpha.com/news/1477071-ariads-iclusig-set-for-market-return-after-fda-approves-revised-uspi-and-rems\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1477041\" data-ts=\"1387552305\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JEC\" target=\"_blank\">JEC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1477041-stephens-starts-coverage-on-construction-services-names\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stephens starts coverage on construction services names</a></h4><ul>\n<li>Stephens is out with coverage initiations for some construction services names.</li>\n<li>Jacobs Engineering (<a href=\"https://seekingalpha.com/symbol/JEC\" title=\"Jacobs Engineering Group Inc.\">JEC</a> <font color=\"green\">+0.4%</font>) <a href=\"http://www.streetinsider.com/New+Coverage/Stephens+Starts+Jacobs+Engineering+%28JEC%29+at+Overweight/8998833.html\" target=\"_blank\">initiated</a> at Overweight. Price target is $68.</li>\n<li>KBR (<a href=\"https://seekingalpha.com/symbol/KBR\" title=\"KBR, Inc.\">KBR</a> <font color=\"green\">+0.4%</font>) <a href=\"http://www.streetinsider.com/news.php?id=8998834\" target=\"_blank\">initiated</a> at Equalweight. Price target is $32.</li>\n<li>Chicago Bridge &amp; Iron (<a href=\"https://seekingalpha.com/symbol/CBI\" title=\"Chicago Bridge &amp; Iron Company\">CBI</a>) <a href=\"http://www.streetinsider.com/news.php?id=8998830\" target=\"_blank\">started</a> at Overweight. Price target is $94.</li>\n<li>Fluor (<a href=\"https://seekingalpha.com/symbol/FLR\" title=\"Fluor Corporation\">FLR</a> <font color=\"green\">+0.1%</font>) <a href=\"http://www.streetinsider.com/news.php?id=8998831\" target=\"_blank\">started</a> at Equalweight. Price target is $82.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1477041\" data-linked=\"Stephens starts coverage on construction services names\" data-tweet=\"$JEC $J $KBR - Stephens starts coverage on construction services names https://seekingalpha.com/news/1477041-stephens-starts-coverage-on-construction-services-names?source=tweet\" data-url=\"https://seekingalpha.com/news/1477041-stephens-starts-coverage-on-construction-services-names\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1477011\" data-ts=\"1387551808\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JCP\" target=\"_blank\">JCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1477011-j-c-penney-perks-up-after-channel-checks-flash-green\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J.C. Penney perks up after channel checks flash green</a></h4><ul> <li>Cleveland Research swings a big stick in the retail sector and is giving J.C. Penney (<a href=\"https://seekingalpha.com/symbol/JCP\" title=\"J.C. Penney Company Inc.\">JCP</a> <font color=\"green\">+5%</font>) a boost today with a <a href=\"https://twitter.com/thenotablecalls/status/414040691673542656\" target=\"_blank\">positive read</a> on the company's December sales trends.</li> <li>Channel checks from the boutique firm show JCP's improving comparable store sales trends continued right through mid-December.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1477011\" data-linked=\"J.C. Penney perks up after channel checks flash green\" data-tweet=\"$JCP - J.C. Penney perks up after channel checks flash green https://seekingalpha.com/news/1477011-j-c-penney-perks-up-after-channel-checks-flash-green?source=tweet\" data-url=\"https://seekingalpha.com/news/1477011-j-c-penney-perks-up-after-channel-checks-flash-green\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1477001\" data-ts=\"1387551789\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCAI\" target=\"_blank\">SCAI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1477001-morgan-stanley-starts-surgical-care-affiliates-at-equalweight\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley starts Surgical Care Affiliates at Equalweight</a></h4><ul>\n<li>Morgan Stanley <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/12/4172842/update-morgan-stanley-initiates-coverage-on-surgical-car\" target=\"_blank\">starts</a> Surgical Care Affiliates (<a href=\"https://seekingalpha.com/symbol/SCAI\" title=\"Surgical Care Affiliates, Inc.\">SCAI</a> <font color=\"red\">-2.9%</font>) at Equalweight, noting a \"balanced risk reward.\"</li>\n<li>Analyst Andrew Schenker thinks the company \"has a capital  efficient acquisition growth strategy [which can] drive improved pricing and  volumes.\u201d</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1477001\" data-linked=\"Morgan Stanley starts Surgical Care Affiliates at Equalweight\" data-tweet=\"$SCAI - Morgan Stanley starts Surgical Care Affiliates at Equalweight https://seekingalpha.com/news/1477001-morgan-stanley-starts-surgical-care-affiliates-at-equalweight?source=tweet\" data-url=\"https://seekingalpha.com/news/1477001-morgan-stanley-starts-surgical-care-affiliates-at-equalweight\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1476951\" data-ts=\"1387550847\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JAZZ\" target=\"_blank\">JAZZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1476951-fbr-talks-jazz-deal-for-gentium\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FBR talks Jazz deal for Gentium</a></h4><ul>\n<li>\"The complex nature of [<a href=\"https://seekingalpha.com/currents/search?query=Defitelio\" target=\"_blank\">Defitelio</a>] could make it difficult to copy, so  we believe it possible that generic competition <a href=\"http://www.streetinsider.com/Analyst+Comments/Jazz+Pharmaceuticals+%28JAZZ%29+Deal+for+Gentium+%27Important%27%2C+FBR+Says%3B+Remains+Top+Pick/8998901.html\" target=\"_blank\">might not emerge</a>,\" FBR's William Tanner says, regarding Jazz Pharmaceuticals' (<a href=\"https://seekingalpha.com/symbol/JAZZ\" title=\"Jazz Pharmaceuticals, Inc.\">JAZZ</a> <font color=\"green\">+7.6%</font>) acquisition of Gentium (GENT <font color=\"green\">+2.5%</font>) and its sVOD treatment.</li>\n<li>\"There may be additional growth opportunities that could  be tapped,\" Tanner adds, noting that \"sale of the drug in Europe is expected to be accomplished  using the <a href=\"https://seekingalpha.com/currents/search?query=Erwinaze\" target=\"_blank\">Erwinaze</a> sales force as the call point is the same.\"</li>\n<li>JAZZ remains a top pick at FBR.</li>\n<li>Also out positive on JAZZ is Brean's Gene Mack who <a href=\"http://www.streetinsider.com/Analyst+Comments/Jazz+Pharma+%28JAZZ%29+PT+Raised+to+%24171+at+Brean+Capital/8999450.html\" target=\"_blank\">lifts the price target</a> on the shares to $171 noting that \"JAZZ is already marketing Erwinaze [in] Europe to hematologists and we  believe having both products in the portfolio will allow [them] to  increase their physician base.\"</li>\n<li>For more, see <a href=\"https://seekingalpha.com/currents/post/1475861\" target=\"_blank\">here</a> and <a href=\"https://seekingalpha.com/currents/post/1476621\" target=\"_blank\">here</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1476951\" data-linked=\"FBR talks Jazz deal for Gentium\" data-tweet=\"$JAZZ $JAZZ $GENTY - FBR talks Jazz deal for Gentium https://seekingalpha.com/news/1476951-fbr-talks-jazz-deal-for-gentium?source=tweet\" data-url=\"https://seekingalpha.com/news/1476951-fbr-talks-jazz-deal-for-gentium\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1476941\" data-ts=\"1387550762\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1476941-blackberry-moving-away-from-high-end-consumer-phone-market\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BlackBerry moving away from high-end consumer phone market</a></h4><ul>\n<li>Chairman/interim CEO <a href=\"http://bgr.com/2013/12/20/blackberry-high-end-smartphone-exit/\" target=\"_blank\">John Chen</a> states on BlackBerry's (BBRY <font color=\"red\">-2.4%</font>) FQ3 CC new OEM partner Foxconn, initially focused on low-end/emerging markets phones, will handle most of BlackBerry's phone design work going forward, and that BlackBerry will only design a limited number of high-end, enterprise-focused phones itself.</li>\n<li>Chen, who has <a href=\"https://seekingalpha.com/currents/post/1440411\" target=\"_blank\">already suggested</a> BlackBerry will be an enterprise-focused company going forward, says he does hope BlackBerry would be able to design its own high-end consumer phones in the future, but thinks the company needs to focus its resources on enterprise software for now.</li>\n<li>One bright spot: BlackBerry says it has added 40M+ registered Android/iOS BBM users since making BBM apps available on the platforms in October. For reference, BlackBerry claimed to have ~60M BBM users on its own devices earlier this year. BlackBerry has promised to <a href=\"http://bgr.com/2013/10/29/bbm-iphone-android-ads-coming/\" target=\"_blank\">eventually monetize</a> Android/iOS users via ads; new value-added services are also a future possibility.</li>\n<li>The first BlackBerry/Foxconn phone will be a <a href=\"http://techcrunch.com/2013/12/20/blackberry-foxconn-phone/\" target=\"_blank\">3G BB10 device</a> likely to arrive in March or April. BlackBerry still has a sizable emerging markets base, but is also facing very tough competition from low-end Android phones, including sub-$100 products from white-label OEMs.</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/1476301\" target=\"_blank\">FQ3 results</a>, <a href=\"https://seekingalpha.com/currents/post/1476371\" target=\"_blank\">details/Foxconn deal</a>, PR</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1476941\" data-linked=\"BlackBerry moving away from high-end consumer phone market\" data-tweet=\"$BB - BlackBerry moving away from high-end consumer phone market https://seekingalpha.com/news/1476941-blackberry-moving-away-from-high-end-consumer-phone-market?source=tweet\" data-url=\"https://seekingalpha.com/news/1476941-blackberry-moving-away-from-high-end-consumer-phone-market\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1476911\" data-ts=\"1387550016\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORCL\" target=\"_blank\">ORCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1476911-oracle-acquiring-responsys-for-27-share-looks-to-take-on-salesforce\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oracle acquiring Responsys for $27/share, looks to take on Salesforce</a></h4><ul>\n<li>Oracle (<a href=\"https://seekingalpha.com/symbol/ORCL\" title=\"Oracle Corporation\">ORCL</a> <font color=\"red\">-0.1%</font>) is acquiring cloud marketing automation software firm Responsys (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MKTG\" title=\"Responsys\">MKTG</a>) for $1.5B, or $27/share, in cash. The price represents a <font color=\"green\">38% premium</font> to Responsys' Thursday close. The deal is expected to close in 1H14.</li>\n<li>Oracle <a href=\"https://seekingalpha.com/currents/post/1335382\" target=\"_blank\">has already made</a> several online/social media marketing software acquisitions in recent years, the largest being its $871M purchase of <a href=\"https://seekingalpha.com/currents/post/730741\" target=\"_blank\">Eloqua</a>. Responsys' products, like Eloqua's, will be added to Oracle's <a href=\"http://www.oracle.com/us/solutions/cloud/cloud-applications/cx/index.html\" target=\"_blank\">Customer Experience Cloud</a>, which offers a number of cloud-based sales/marketing software products..</li>\n<li>Oracle is doubtlessly looking to better compete against Salesforce (<a href=\"https://seekingalpha.com/symbol/CRM\" title=\"Salesforce.com, Inc.\">CRM</a> <font color=\"green\">+0.5%</font>), which just <a href=\"https://seekingalpha.com/currents/post/1062691\" target=\"_blank\">spent $2.5B</a> to buy marketing automation software vendor ExactTarget. The deal fueled hopes Responsys or Marketo (<a href=\"https://seekingalpha.com/symbol/MKTO\" title=\"Marketo\">MKTO</a>) would be acquired as well. Marketo and Constant Contact (<a href=\"https://seekingalpha.com/symbol/CTCT\" title=\"Constant Contact, Inc.\">CTCT</a> <font color=\"green\">+4.2%</font>) are trading higher in response to the deal.</li>\n<li>Adobe (<a href=\"https://seekingalpha.com/symbol/ADBE\" title=\"Adobe Systems Incorporated\">ADBE</a>) is also moving aggressively in this space; it recently bought French marketing automation vendor <a href=\"https://seekingalpha.com/currents/post/1111122\" target=\"_blank\">Neolane</a> for $600M. Oracle, Salesforce, and Adobe, along with SAP and IBM, are each trying to profit from an ongoing shift in ad spend towards digital channels (inc. social media), and a <a href=\"https://seekingalpha.com/currents/post/1292772\" target=\"_blank\">shift in IT spend</a> towards CMOs.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1476911\" data-linked=\"Oracle acquiring Responsys for $27/share, looks to take on Salesforce\" data-tweet=\"$ORCL $ORCL $MKTG - Oracle acquiring Responsys for $27/share, looks to take on Salesforce https://seekingalpha.com/news/1476911-oracle-acquiring-responsys-for-27-share-looks-to-take-on-salesforce?source=tweet\" data-url=\"https://seekingalpha.com/news/1476911-oracle-acquiring-responsys-for-27-share-looks-to-take-on-salesforce\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1476861\" data-ts=\"1387548955\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NAV\" target=\"_blank\">NAV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1476861-navistar-puts-in-weak-quarter-shares-minus-5_5-percent-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Navistar puts in weak quarter, shares -5.5% premarket</a></h4><ul> <li>Navistar (NYSE:<a href=\"https://seekingalpha.com/symbol/NAV\" title=\"Navistar International Corporation\">NAV</a>) saw a big drop in revenue during its <a href=\"https://seekingalpha.com/currents/post/1476331\" target=\"_blank\">FQ4</a> due in part to light orders from the U.S. military.</li> <li>Higher warranty costs were a drag on the company's bottom line during the period.</li> <li>The quarterly results come amid a major shift in engine strategy at Navistar.</li> <li>NAV <font color=\"red\">-5.5%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1476861\" data-linked=\"Navistar puts in weak quarter, shares -5.5% premarket\" data-tweet=\"$NAV - Navistar puts in weak quarter, shares -5.5% premarket https://seekingalpha.com/news/1476861-navistar-puts-in-weak-quarter-shares-minus-5_5-percent-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/1476861-navistar-puts-in-weak-quarter-shares-minus-5_5-percent-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1476831\" data-ts=\"1387548800\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BCRX\" target=\"_blank\">BCRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1476831-biocryst-submits-peramivir-nda\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioCryst submits peramivir NDA</a></h4><ul>\n<li>BioCryst Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/BCRX\" title=\"BioCryst Pharmaceuticals, Inc.\">BCRX</a>) jumps <font color=\"green\">5.7% </font>before the bell.</li>\n<li>The company has submitted a NDA for IV <a href=\"https://seekingalpha.com/currents/search?query=peramivir\" target=\"_blank\">peramivir</a> in acute uncomplicated influenza in adults.</li>\n<li>BCRX got a small business waiver for the application fee. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1476831\" data-linked=\"BioCryst submits peramivir NDA\" data-tweet=\"$BCRX - BioCryst submits peramivir NDA https://seekingalpha.com/news/1476831-biocryst-submits-peramivir-nda?source=tweet\" data-url=\"https://seekingalpha.com/news/1476831-biocryst-submits-peramivir-nda\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1476821\" data-ts=\"1387548696\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1476821-premarket-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers</a></h4><ul>\n<li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/ORMP\" title=\"Oramed Pharmaceuticals Inc.\">ORMP</a> <font color=\"green\">+36%</font>. <a href=\"https://seekingalpha.com/symbol/TSEM\" title=\"Tower Semiconductor Ltd.\">TSEM</a> <font color=\"green\">+33%</font>. <a href=\"https://seekingalpha.com/symbol/AMRN\" title=\"Amarin Corporation PLC\">AMRN</a> <font color=\"green\">+23%</font>. <a href=\"https://seekingalpha.com/symbol/RHT\" title=\"Red Hat, Inc.\">RHT</a> <font color=\"green\">+14%</font>. APRI <font color=\"green\">+13%</font>. <a href=\"https://seekingalpha.com/symbol/CLWT\" title=\"Euro Tech Holdings Company Limited\">CLWT</a> <font color=\"green\">+14%</font>. <a href=\"https://seekingalpha.com/symbol/JAZZ\" title=\"Jazz Pharmaceuticals, Inc.\">JAZZ</a> <font color=\"green\">+8%</font>. <a href=\"https://seekingalpha.com/symbol/FINL\" title=\"The Finish Line, Inc.\">FINL</a> <font color=\"green\">+7%</font>.</li>\n<li>\n<b>Losers:</b> WPCS <font color=\"red\">-26%</font>. <a href=\"https://seekingalpha.com/symbol/TIBX\" title=\"TIBCO Software, Inc.\">TIBX</a> <font color=\"red\">-12%</font>. <a href=\"https://seekingalpha.com/symbol/NAVB\" title=\"Navidea Biopharmaceuticals\">NAVB</a> <font color=\"red\">-11%</font>. <a href=\"https://seekingalpha.com/symbol/KMX\" title=\"CarMax Group\">KMX</a> <font color=\"red\">-5%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1476821\" data-linked=\"Premarket Gainers / Losers\" data-tweet=\"$ORMP $TSEM $AMRN - Premarket Gainers / Losers https://seekingalpha.com/news/1476821-premarket-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1476821-premarket-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1476791\" data-ts=\"1387548435\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORMP\" target=\"_blank\">ORMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1476791-oramed-soars-on-successful-results-with-oral-insulin-capsule-in-t1dm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oramed soars on successful results with oral insulin capsule in T1DM</a></h4><ul>\n<li>Oramed Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ORMP\" title=\"Oramed Pharmaceuticals Inc.\">ORMP</a>) rises <font color=\"green\">34%</font> in premarket trading.</li>\n<li>The company says \"patient responses positively correlated with administered doses, as did the duration of the effect,\" in a study testing the pharmacokinetic dose response of ORMD-0801 in type 1 diabetes.</li>\n<li>ORMP will \"continue to move forward with this indication\" along with studies in type 2 diabetes. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1476791\" data-linked=\"Oramed soars on successful results with oral insulin capsule in T1DM\" data-tweet=\"$ORMP - Oramed soars on successful results with oral insulin capsule in T1DM https://seekingalpha.com/news/1476791-oramed-soars-on-successful-results-with-oral-insulin-capsule-in-t1dm?source=tweet\" data-url=\"https://seekingalpha.com/news/1476791-oramed-soars-on-successful-results-with-oral-insulin-capsule-in-t1dm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1476621\" data-ts=\"1387546096\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JAZZ\" target=\"_blank\">JAZZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1476621-jazz-rises-following-1b-deal-for-gentium\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jazz rises following $1B deal for Gentium</a></h4><ul>\n<li>Shares of Jazz Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/JAZZ\" title=\"Jazz Pharmaceuticals, Inc.\">JAZZ</a>) are <font color=\"green\">7%</font> higher in thin premarket trading on the heels of the company's Gentium (GENT) <a href=\"https://seekingalpha.com/currents/post/1475861\" target=\"_blank\">acquisition</a>.</li>\n<li>The deal gives the company <a href=\"https://seekingalpha.com/currents/search?query=Defitelio\" target=\"_blank\">Defitelio</a> \u2014 the sVOD treatment that also has an Orphan designation in the EU for GvHD \u2014 which JAZZ says \"is highly complementary to [the company's] experience in and focus on orphan diseases in the area of hematology/oncology.\"</li>\n<li>JAZZ expects the deal to be immediately accretive. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1476621\" data-linked=\"Jazz rises following $1B deal for Gentium\" data-tweet=\"$JAZZ $JAZZ $GENTY - Jazz rises following $1B deal for Gentium https://seekingalpha.com/news/1476621-jazz-rises-following-1b-deal-for-gentium?source=tweet\" data-url=\"https://seekingalpha.com/news/1476621-jazz-rises-following-1b-deal-for-gentium\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1476571\" data-ts=\"1387545347\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NKE\" target=\"_blank\">NKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1476571-nikes-profits-is-the-shine-coming-off-the-swoosh\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nike&#39;s profits: Is the shine coming off the swoosh?</a></h4><ul> <li>Concerns about the <a href=\"https://twitter.com/HedgeyeRetail/status/413991030820581376\" target=\"_blank\">higher cost pressures</a> Nike (NYSE:<a href=\"https://seekingalpha.com/symbol/NKE\" title=\"Nike Inc.\">NKE</a>) is facing appears to be taking away some of the enthusiasm over the company's <a href=\"https://seekingalpha.com/currents/post/1476111\" target=\"_blank\">strong revenue forecast</a> and global futures orders count.</li> <li>In its latest quarter, the company only <a href=\"https://twitter.com/HedgeyeRetail/status/413991292683563009\" target=\"_blank\">managed</a> 4% EPS growth off of a 8% sales gain on margin pressures which didn't improve with scale.</li> <li>NKE <font color=\"green\">+0.2%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1476571\" data-linked=\"Nike&#39;s profits: Is the shine coming off the swoosh?\" data-tweet=\"$NKE - Nike&#39;s profits: Is the shine coming off the swoosh? https://seekingalpha.com/news/1476571-nikes-profits-is-the-shine-coming-off-the-swoosh?source=tweet\" data-url=\"https://seekingalpha.com/news/1476571-nikes-profits-is-the-shine-coming-off-the-swoosh\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1476471\" data-ts=\"1387543904\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FINL\" target=\"_blank\">FINL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1476471-finish-line-races-higher-following-strong-quarter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Finish Line races higher following strong quarter</a></h4><ul>     <li>Finish Line (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FINL\" title=\"The Finish Line, Inc.\">FINL</a>) reports comparable store sales rose 7.1% in Q3 as its omni-channel platform performed well.</li>     <li>At the end of the quarter, the company had no interest-bearing debt and $111.9M in cash.</li>     <li>The retailer expects full-year EPS of $1.60-$1.65 vs. $1.59 consensus (PR).</li>     <li>FINL <font color=\"green\">+8.3%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1476471\" data-linked=\"Finish Line races higher following strong quarter\" data-tweet=\"$FINL - Finish Line races higher following strong quarter https://seekingalpha.com/news/1476471-finish-line-races-higher-following-strong-quarter?source=tweet\" data-url=\"https://seekingalpha.com/news/1476471-finish-line-races-higher-following-strong-quarter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1476451\" data-ts=\"1387543315\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WBA\" target=\"_blank\">WBA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1476451-walgreen-higher-after-reporting-in-line-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Walgreen higher after reporting in-line results</a></h4><ul>     <li>Walgreen (WAG) reports front-end comparable store sales rose 2.4% in FQ1.</li>     <li>The drugstore operator saw a mild 0.2% increase in traffic, but the average basket size during the period was 2.2% higher Y/Y.</li>     <li>Prescription sales were up 7.3%.</li>     <li>On Alliance Boots: The acquisition contributed $0.14 to Walgreen's bottom line, half of which was a deferred tax adjustment. The company estimates that the accretion from Alliance Boots in FQ2 will be $0.07-$0.08.</li>     <li>WAG <font color=\"green\">+1.6%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1476451\" data-linked=\"Walgreen higher after reporting in-line results\" data-tweet=\"$WBA - Walgreen higher after reporting in-line results https://seekingalpha.com/news/1476451-walgreen-higher-after-reporting-in-line-results?source=tweet\" data-url=\"https://seekingalpha.com/news/1476451-walgreen-higher-after-reporting-in-line-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1476441\" data-ts=\"1387543200\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1476441-blackberry-reopens-tumbles-6_2-percent\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BlackBerry reopens - tumbles 6.2%</a></h4><ul><li>Reopened for trade following <a href=\"https://seekingalpha.com/currents/post/1476371\" target=\"_blank\">FQ3 results</a>, BlackBerry (BBRY) is&nbsp;<font color='red'>off 6.2%&nbsp;</font>in early action.</li></ul><div class=\"tiny-share-widget\" data-id=\"1476441\" data-linked=\"BlackBerry reopens - tumbles 6.2%\" data-tweet=\"$BB - BlackBerry reopens - tumbles 6.2% https://seekingalpha.com/news/1476441-blackberry-reopens-tumbles-6_2-percent?source=tweet\" data-url=\"https://seekingalpha.com/news/1476441-blackberry-reopens-tumbles-6_2-percent\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1476381\" data-ts=\"1387542304\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMRN\" target=\"_blank\">AMRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1476381-fda-delays-ruling-on-expanding-use-of-amarins-vascepa-shares-soar\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA delays ruling on expanding use of Amarin&#39;s Vascepa; shares soar</a></h4><ul>   <li>The FDA has indefinitely delayed a ruling on Amarin's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AMRN\" title=\"Amarin Corporation PLC\">AMRN</a>) request to expand the use of of the company's Vascepa drug, which lowers triglyceride fat in blood.  Under the new \"ANCHOR\" indication, the therapy would be used to treat people who take statins to cut cholesterol and have a high risk of coronary heart disease.</li>    <li>The FDA was due to issue its verdict today, but the agency put off the ruling as it's still considering Amarin's request to re-instate the ANCHOR Special Protocol Assessment (NYSE:<a href=\"https://seekingalpha.com/symbol/SPA\" title=\"Sparton Corporation\">SPA</a>) agreement. Under the SPA, the FDA had said that the design of an uncompleted  Phase III trial was acceptable to support a marketing application to widen Vascepa's use case.</li>    <li>However, the agency rescinded that SPA in October and initially denied Amarin's appeal over the matter.</li>    <li>The FDA has also said that it views that appeal as separate from the firm's request to expand the use of Vascepa.</li>    <li>Amarin shares are <font color=\"green\">+32%</font>. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1476381\" data-linked=\"FDA delays ruling on expanding use of Amarin&#39;s Vascepa; shares soar\" data-tweet=\"$AMRN $AMRN $SPA - FDA delays ruling on expanding use of Amarin&#39;s Vascepa; shares soar https://seekingalpha.com/news/1476381-fda-delays-ruling-on-expanding-use-of-amarins-vascepa-shares-soar?source=tweet\" data-url=\"https://seekingalpha.com/news/1476381-fda-delays-ruling-on-expanding-use-of-amarins-vascepa-shares-soar\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1476371\" data-ts=\"1387542182\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1476371-blackberry-sells-4_3m-phones-sets-deal-with-foxconn-for-emerging-markets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BlackBerry sells 4.3M phones; sets deal with Foxconn for emerging markets</a></h4><ul>\n<li>Revenue of $1.2B in FQ3 is off 24% Q/Q, off 56% from a year ago. About 4.3M smartphones were sold to end customers, about 3.2M of those were BlackBerry 7 devices. Company takes $4.6B in non-cash, pre-tax charges amid inventory write-downs and restructuring.</li>\n<li>Cash and cash equivalents rise to $3.2B as of the end of November from $2.6B one quarter earlier.</li>\n<li>Company enters a 5-year strategic partnership with Foxconn to go after emerging markets - the initial target (early 2014) will be a smartphone for Indonesia and other fast-growing markets.</li>\n<li>\n<a href=\"http://ca.blackberry.com/company/investors/events.html\" target=\"_blank\">CC</a> at 8 ET</li>\n<li>BBRY halted until 7:30 ET.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1476371\" data-linked=\"BlackBerry sells 4.3M phones; sets deal with Foxconn for emerging markets\" data-tweet=\"$BB - BlackBerry sells 4.3M phones; sets deal with Foxconn for emerging markets https://seekingalpha.com/news/1476371-blackberry-sells-4_3m-phones-sets-deal-with-foxconn-for-emerging-markets?source=tweet\" data-url=\"https://seekingalpha.com/news/1476371-blackberry-sells-4_3m-phones-sets-deal-with-foxconn-for-emerging-markets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1476231\" data-ts=\"1387535477\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1476231-european-stocks-continue-fed-induced-rally\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">European stocks continue Fed-induced rally</a></h4><ul>   <li>Asian shares are mixed but <a href=\"http://www.reuters.com/article/2013/12/20/markets-global-idUSL6N0JZ1JT20131220\" target=\"_blank\">European equities</a> are heading for their best week since April, with markets continuing to bask in the glow of the Fed's dovish taper.</li>    <li>\n<a href=\"https://seekingalpha.com/currents/post/1476161\" target=\"_blank\">As noted</a> earlier, Chinese shares fell sharply amid concerns about another cash crunch as money market rates spiked again.</li>    <li>Japan <font color=\"green\">+0.1%</font>, Hong Kong <font color=\"red\">-0.3%</font>, China <font color=\"red\">-2%</font>, India <font color=\"green\">+1.8%</font>.</li>    <li>EU Stoxx 50 <font color=\"green\">+0.6%</font>, London <font color=\"green\">+0.4%</font>, Paris <font color=\"green\">+0.2%</font>, Frankfurt <font color=\"green\">+0.6%</font>, Milan <font color=\"green\">+0.1%</font>, Madrid <font color=\"green\">+0.2%</font>.</li>     <li>U.S. stock futures: Dow <font color=\"green\">+0.15%</font>. S&amp;P <font color=\"green\">+0.2%</font>. Nasdaq <font color=\"green\">+0.2%</font>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"1476231\" data-linked=\"European stocks continue Fed-induced rally\" data-tweet=\"European stocks continue Fed-induced rally https://seekingalpha.com/news/1476231-european-stocks-continue-fed-induced-rally?source=tweet\" data-url=\"https://seekingalpha.com/news/1476231-european-stocks-continue-fed-induced-rally\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1476161\" data-ts=\"1387528589\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1476161-chinese-shares-suffer-worst-run-for-19-years-amid-cash-crunch\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chinese shares suffer worst run for 19 years amid cash crunch</a></h4><ul>    <li>Chinese stocks have closed down for the <a href=\"http://www.sfgate.com/business/bloomberg/article/China-s-Money-Rates-Climb-Stocks-Slide-as-Cash-5080899.php\" target=\"_blank\">ninth consecutive session</a>, the worst run since 1994, amid increasing fears of another cash crunch in the short-term money markets.</li>    <li>The seven-day repurchase rate soared 100 bps to a six-month high of 7.6%, representing a jump of 328 bps this week.</li>    <li>The spike came as borrowing <a href=\"http://online.wsj.com/news/articles/SB10001424052702304773104579269211799066166\" target=\"_blank\">remained difficult</a> despite the People's Bank of China making an emergency cash injection in the financial system yesterday after being inactive for over two weeks. The PBOC didn't provide too many details, although the amount was reported to be 200B yuan ($32.9B).</li>    <li>\"Market participants have to be able to see it and know the quantity and tenor of liquidity assistance in order to be reassured,\" says HSBC's Pin Ru Tan. \"If they do not, it is natural to remain cautious.</li>\n<li>The Shanghai composite <font color=\"red\">fell 2%</font> and the Hang Seng <font color=\"red\">-0.2%</font>.</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/fxi\" title=\"iShares China Large-Cap ETF\">FXI</a>, <a href=\"https://seekingalpha.com/symbol/pgj\" title=\"PowerShares Golden Dragon China Portfolio ETF\">PGJ</a>, <a href=\"https://seekingalpha.com/symbol/gxc\" title=\"SPDR S&amp;P China ETF\">GXC</a>, <a href=\"https://seekingalpha.com/symbol/fxp\" title=\"ProShares UltraShort FTSE China 25 ETF\">FXP</a>, <a href=\"https://seekingalpha.com/symbol/hao\" title=\"Guggenheim China Small Cap ETF \">HAO</a>, <a href=\"https://seekingalpha.com/symbol/cyb\" title=\"WisdomTree Chinese Yuan ETF\">CYB</a>, <a href=\"https://seekingalpha.com/symbol/yinn\" title=\"Direxion Daily FTSE China Bull 3X Shares ETF\">YINN</a>, <a href=\"https://seekingalpha.com/symbol/cny\" title=\"Market Vectors Chinese Renminbi/USD ETN\">CNY</a>, <a href=\"https://seekingalpha.com/symbol/tao\" title=\"Guggenheim China Real Estate ETF \">TAO</a>, <a href=\"https://seekingalpha.com/symbol/chiq\" title=\"Global X China Consumer ETF\">CHIQ</a>, <a href=\"https://seekingalpha.com/symbol/chix\" title=\"Global X China Financial ETF\">CHIX</a>, <a href=\"https://seekingalpha.com/symbol/mchi\" title=\"iShares MSCI China ETF\">MCHI</a>, <a href=\"https://seekingalpha.com/symbol/yang\" title=\"Direxion Daily FTSE China Bear 3x Shares ETF\">YANG</a>, <a href=\"https://seekingalpha.com/symbol/pek\" title=\"Market Vectors China ETF \">PEK</a>, <a href=\"https://seekingalpha.com/symbol/ashr\" title=\"db X-trackers Harvest China ETF\">ASHR</a>, <a href=\"https://seekingalpha.com/symbol/cqqq\" title=\"Guggenheim China Technology ETF \">CQQQ</a>, <a href=\"https://seekingalpha.com/symbol/xpp\" title=\"ProShares Ultra FTSE China 25 ETF\">XPP</a>, <a href=\"https://seekingalpha.com/symbol/qqqc\" title=\"Global X China Technology ETF\">QQQC</a>, <a href=\"https://seekingalpha.com/symbol/dsum\" title=\"PowerShares Chinese Yuan Dim Sum Bond Portfolio ETF\">DSUM</a>, <a href=\"https://seekingalpha.com/symbol/yao\" title=\"Guggenheim China All-Cap ETF \">YAO</a>, <a href=\"https://seekingalpha.com/symbol/chxx\" title=\"EGShares China Infrastructure ETF\">CHXX</a>, <a href=\"https://seekingalpha.com/symbol/chii\" title=\"Global X China Industrial ETF\">CHII</a>, <a href=\"https://seekingalpha.com/symbol/fxch\" title=\"CurrencyShares Chinese Renminbi Trust ETF\">FXCH</a>, <a href=\"https://seekingalpha.com/symbol/chxf\" title=\"WisdomTree China Dividend ex-Financials ETF\">CHXF</a>, <a href=\"https://seekingalpha.com/symbol/kweb\" title=\"KraneShares CSI China Internet ETF\">KWEB</a>, <a href=\"https://seekingalpha.com/symbol/ecns\" title=\"iShares MSCI China Small-Cap ETF\">ECNS</a>, <a href=\"https://seekingalpha.com/symbol/chie\" title=\"Global X China Energy ETF\">CHIE</a>, <a href=\"https://seekingalpha.com/symbol/yxi\" title=\"ProShares Short FTSE China 25 ETF\">YXI</a>, <a href=\"https://seekingalpha.com/symbol/chim\" title=\"Global X China Materials ETF\">CHIM</a>, <a href=\"https://seekingalpha.com/symbol/kfyp\" title=\"KraneShares CSI China Five Year Plan ETF\">KFYP</a>, <a href=\"https://seekingalpha.com/symbol/fca\" title=\"First Trust China AlphaDEX ETF\">FCA</a>, <a href=\"https://seekingalpha.com/symbol/tchi\" title=\"RBS China Trendpilot ETN\">TCHI</a>, <a href=\"https://seekingalpha.com/symbol/chlc\" title=\"Market Vectors Renminbi Bond ETF\">CHLC</a>, <a href=\"https://seekingalpha.com/symbol/chna\" title=\"PowerShares China A - Share Portfolio ETF\">CHNA</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1476161\" data-linked=\"Chinese shares suffer worst run for 19 years amid cash crunch\" data-tweet=\"$FXI $PGJ $GXC - Chinese shares suffer worst run for 19 years amid cash crunch https://seekingalpha.com/news/1476161-chinese-shares-suffer-worst-run-for-19-years-amid-cash-crunch?source=tweet\" data-url=\"https://seekingalpha.com/news/1476161-chinese-shares-suffer-worst-run-for-19-years-amid-cash-crunch\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":40,"message":null,"success":true,"today":{"start":1576818000,"end":1576904399,"str":"Friday, December 20, 2019"},"yesterday":{"start":1576731600,"end":1576817999}}